Sick day rules for people living with type 2 diabetes Acute illness can affect blood glucose control and increase the risk of type 2 diabetes mellitus complications. This article summarises sick day rules and how pharmacists can provide patients with information, advice and support.…
A prescribing service for pharmacies in England: everything you need to know What can the pharmacy sector expect from an NHS prescribing service in England and how will it be carried out?…
Medicines regulator to outsource some drug assessment work to private firms The Medicines and Healthcare products Regulatory Agency said that three companies have been given contracts to provide assessments of clinical and non-clinical regulatory data.…
Communication of risks of psychiatric side effects with fluoroquinolone antibiotics to be reviewed following death A patient who had taken his own life began taking prescribed ofloxacin the day before his death after a previously prescribed first-line antibiotic had been ineffective.…
MHRA extends approval for gene-editing therapy to patients aged five years and over Casgevy will now be used to treat younger patients with sickle-cell disease or transfusion-dependent β-thalassemia.…
Scotland to require registration for anyone selling vaping and nicotine products The Scottish government said that registration will not be required for the sale of medically licensed products such as nicotine replacement therapies.…
NHS prescribing of GLP-1 drugs varies tenfold by location, says ABPI An Association of the British Pharmaceutical Industry report highlighted that barriers to accessing GLP-1 drugs included a lack of local renumeration arrangements and delays in health boards adding drugs to local formularies.…
Use of Pharmacy First has increased by nearly 60% since the service began Data from Public Health Scotland also showed that in 2025/2026, 36% of the Scottish population used the Pharmacy First Scotland service at least once.…
Personalised cancer vaccine with immunotherapy cuts risk of melanoma returning by 42%, study finds After two years, 82% of patients who received the combination of pembrolizumab with the intismeran autogene vaccine were alive without recurrence of high-risk melanoma.…
New medicines need workable pathways towards delivery, not just formulary approval Even after MHRA approval, a NICE recommendation and formulary inclusion, there is still a long way to go before patients can benefit from new medicines.…